1-10 of 10
Ying Tian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mitoxantrone Hydrochloride Liposome, Proteasome Inhibitors, Pomalidomide and Dexamethasone Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma in China

Menghan Liu, Jigang Wang, Haiguo Zhang, Ying Tian, Hongming Huang, Yan Wang, Qing Leng, Wenming Chen, Aijun Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7072.
https://doi.org/10.1182/blood-2024-210174
Published: 2024
Journal Articles

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

Ying Tian, Keshu Zhou, Quande Lin, Wenbin Qian, Wei Yang, Li Bao, Guolin Yuan, Xiaojing Yan, Liangming Ma, Xin Zhou, Lihong Liu, Fangbing Zhu, Xuelan Zuo, Xin Du, Xu Ji, Xuzhao Zhang, Jing Shen, Hai Zhou, Na Li, Wenming Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4746.
https://doi.org/10.1182/blood-2024-199381
Published: 2024
Journal Articles

The Efficacy and Safety of Zanubrutinib, Dexamethasone and or Not Cyclophosphamide Regimen in Symptomatic Waldenstrom Macroglobulinnemia

Aijun Liu, Jin Lu, Yanping Ma, Da Gao, Luoming Hua, Yuechen Zhang, Chuanying Geng, Ying Tian, Yun Leng, Wenming Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6699.
https://doi.org/10.1182/blood-2023-189130
Published: 2023
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Hong Yu, Lei Shi, Wei-wei Tian, Qinhua Liu, Dongmei Zou, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Wanling Sun, Liangming Ma, Li Bao, Rong Fu, Yin Wu, Chen Wenming, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12637–12639.
https://doi.org/10.1182/blood-2022-169057
Published: 2022
Journal Articles

Lenalidomide Versus Thalidomide or Bortezomib As Maintenance Regimens for Non-Transplant Patients with Multiple Myeloma: Multi-Center Real World Experience in China

Zhe Zhuang, Lei Shi, Ying Tian, Dongmei Zou, Ru Feng, Fei Dong, Yanping Ma, Hong Yu, Wei-wei Tian, Shuangjiao Liu, Liangming Ma, Rong Fu, Hongmei Jing, Hui Liu, Wanling Sun, Chen Wenming, Yin Wu, Li Bao, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4728.
https://doi.org/10.1182/blood-2021-149502
Published: 2021
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Wei-wei Tian, Hong Yu, Dongmei Zou, Qinhua Liu, Lei Shi, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Li Bao, Wanling Sun, Rong Fu, Liangming Ma, Chen Wenming, Yin Wu, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4766.
https://doi.org/10.1182/blood-2021-152542
Published: 2021
Journal Articles

Invasive Field Radiotherapy Combined with Rituximab Versus Rituximab Alone for Consolidation Therapy in Stage III Follicular Lymphoma Patients Response to R-CHOP Chemotherapy: A Randomized Clinical Study

Tongyu Lin, He Huang, Xiaoqian Li, Huangming Hong, Liqun Zou, Liling Zhang, Zhihui Zhang, Zhongjun Xia, Yongchang Chen, Meiting Chen, Zegeng Chen, Xiaojie Fang, Hongqiang Guo, Ke Xie, Ying Tian, Suxia Lin, Wei Zhang, Yuyi Yao, Fei Pan, Huawei Weng
Journal: Blood
Blood (2021) 138 (Supplement 1): 3531.
https://doi.org/10.1182/blood-2021-146338
Published: 2021
Journal Articles

New Insight into Epstein-Barr Virus-Associated Biological Behavior of Aggressive Natural Killer Cell Leukemia

Hongsheng Zhou, MD PhD, Chanxin Yin, Yongjian Deng, Xiaolei Xue, Xiangzhao Li, Ying Tian, Hongsheng Li, Libin Liao, Dan Fang, Min Dai, Qiang Wang, Na Xu, Fen Huang, Zhiping Fan, Yu Zhang, Yongqiang Wei, MD, Dan Xu, Qianli Jiang, Xiaoli Liu, Jing Sun, Qifa Liu, Bing Xu, MD, Ru Feng, Bing Z Carter, PhD, Fanyi Meng
Journal: Blood
Blood (2014) 124 (21): 3002.
https://doi.org/10.1182/blood.V124.21.3002.3002
Published: 2014
Journal Articles

Predictive value of therapeutic monitoring with plasma Epstein-Barr virus DNA in Extranodal NK/T cell lymphoma, nasal type

Chengcheng Guo, He Huang, MD, Ying Tian, Xueying Li, Mengping Zhang, Huangming Hong, MD, Xiaohong Fu, Xiaoting Lin, Shanshan Li, Raj Shrestha Prem, Zhongjun Xia, MD, Tongyu Lin, MDPhD
Journal: Blood
Blood (2014) 124 (21): 5363.
https://doi.org/10.1182/blood.V124.21.5363.5363
Published: 2014
Journal Articles

Prognostic impact of circulating Epstein-Barr virus (EBV) DNA concentration and EBV serology in 125 extranodal NK/T cell lymphoma, nasal type (ENKL) patients

Chengcheng Guo, Huang He, Hongqiang Guo, Jian Xiao, Yujing Zhang, Ying Tian, Yabing Cao, Xiaohong Fu, Linzhu Zhai, Tongyu Lin
Journal: Blood
Blood (2010) 116 (21): 4148.
https://doi.org/10.1182/blood.V116.21.4148.4148
Published: 2010